The impact of sarcopenia on clinical outcomes in men with metastatic castrate-resistant prostate cancer.

Efthymios PapadopoulosAndy Kin On WongSharon Hiu Ching LawLindsey Ze Jing ZhangHenriette BreunisUrban EmmeneggerShabbir Muhammad Husayn Alibhai

Published in: PloS one (2023)

Baseline sarcopenia predicts radiographic progression and overall mortality in men with mCRPC regardless of the type of treatment and may also predict severe treatment toxicity and ER visits in men initiating ARAT.

Keyphrases

prostate cancer
small cell lung cancer
oxidative stress
middle aged
squamous cell carcinoma
radical prostatectomy
cardiovascular disease
coronary artery disease
estrogen receptor
breast cancer cells